Qingbin Cui

6PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesMolecular targetsGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 01, 2025
Investigation of the anticancer efficacy and impact on energy metabolism of dual-core gold(i) complex BGC2a.

Hai-Ling Gao, Wenwen Ding, Zhi-Xin Shen

|Dec 13, 2023
Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.

Qingbin Cui, Caoqinglong Huang, Jing-Yuan Liu

|Oct 27, 2022
Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells.

Qingbin Cui, Wenwen Ding, Panpan Liu

|Mar 06, 2021
The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter.

Silpa Narayanan, Nehaben A Gujarati, Jing-Quan Wang

|Aug 25, 2019
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.

Qingbin Cui, Chao-Yun Cai, Jing-Quan Wang

Pageof 1